Panel 1: Supply Chain Management & Anti-Microbial Resistance
Anti-Microbial Resistance (AMR) is an increasingly serious threat to global public health that requires action across all government sectors and society. Without effective antibiotics, the success of major surgery and cancer chemotherapy would be compromised. In 2016 for example, 490 000 people developed multi-drug resistant TB globally, and drug resistance is beginning to complicate the fight against HIV and malaria, as well. The panel discussion brings to the summit discussion around the pharmaceutical value chain and AMR. Specifically, we will be answering questions on new approaches-systems and tools- to address AMR. The panelists for this panel discussion come from the pharmaceutical industry, leading international development partners, national governments, implementing partners and faith based organizations. At the end of the session the GHSC will come up with recommendations that would help both the donor community and recipient countries to address AMR issues.
Moderator:
Dr. Lloyd Matowe, Program Director, Pharmaceutical Systems Africa
Panelists:
- Mohan Joshi, MSH
- Mirfin Mpundu, EPN
- Linus Odoemene, FMOH, Nigeria
- Gavin Steel, DOH, South Africa